SIREN : 804874527
SAS PHARMADININA is a French company founded 11 years ago, specialized in the sector Centrales d'achat non alimentaires. Based in LE LAMENTIN (97232), this company of category PME shows in 2021 a revenue of 5.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | 5 304 973 € | 5 564 542 € |
| Net income | 73 231 € | 78 219 € | 46 927 € | 67 104 € | 62 082 € |
| EBITDA | N/C | N/C | N/C | -5 309 € | 82 282 € |
| Net margin | N/C | N/C | N/C | 1.3% | 1.1% |
In 2024, SAS PHARMADININA generates positive net income of 73 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2024: 62 k€ -> 73 k€.
73 231 €
The debt ratio (= Financial debt / Equity x 100) stands at 151%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 20%. The balance between equity and debt is satisfactory.
151.285%
20.316%
71.3%
In 2024, the debt ratio of SAS PHARMADININA (151.28) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
In 2024, the financial autonomy of SAS PHARMADININA (20.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
The liquidity ratio (= Current assets / Current liabilities) stands at 192.76. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
192.759
In 2024, the liquidity ratio of SAS PHARMADININA (192.76) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 85 transactions of similar company sales
(all years),
the value of SAS PHARMADININA is estimated at
100 550 €
(range 47 944€ - 515 540€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 85 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare SAS PHARMADININA with other companies in the same sector:
Voir toutes les statistiques du secteur Centrales d'achat non alimentaires
The revenue of SAS PHARMADININA in 2021 is 5.3 M€.
Yes, SAS PHARMADININA generated a net profit of 73 k€ in 2024.
The headquarters of SAS PHARMADININA is located in LE LAMENTIN (97232), in the department Martinique.
The tax return of SAS PHARMADININA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
SAS PHARMADININA operates in the sector Centrales d'achat non alimentaires (NAF code 46.19A). See the 'Sector positioning' section above to compare the company with its competitors.